on being 2 to 3L/kg bodyweight.
Guaifenesin is readily absorbed from the gastrointestinal tract. It is rapidly metabolised and excreted in the urine.
5.3 Preclinical safety data
There are no preclinical data of relevance to the prescriber which are additional to that already included.
6. Pharmaceutical particulars
6.1 List of excipients
Maltitol liquid (E965)
Hyetellose
Glycerol (E422)
Menthol flavour E43525
Acesulfame potassium (E950)
Potassium sorbate (E202)
Citric acid monohydrate
Sodium citrate
Smoke flavour 15852117 (containing ethanol)
Lemon oil
Purified water
6.2 Incompatibilities
None stated
6.3 Shelf life
24 months
6.4 Special precautions for storage
Do not store above 30°C
6.5 Nature and contents of container
120ml amber PET bottle with a child resistant polypropylene cap fitted with an expanded polyethylene liner.
or
120ml white flint or amber glass bottle with a child resistant polypropylene cap fitted with an expanded polyethylene liner.
6.6 Special precautions for disposal and other handling
Not applicable.
7. Marketing authorisation holder
The Boots Company PLC
1 Thane Road West
Nottingham NG2 3AA
8. Marketing authorisation number(s)
PL 00014/0604
9. Date of first authorisation/renewal of the authorisation
4 March 1998
10. Date of revision of the text
March 2013